Your browser doesn't support javascript.
loading
Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer.
Liu, Yunhua; Zhang, Xinna; Han, Cecil; Wan, Guohui; Huang, Xingxu; Ivan, Cristina; Jiang, Dahai; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Rao, Pulivarthi H; Maru, Dipen M; Pahl, Andreas; He, Xiaoming; Sood, Anil K; Ellis, Lee M; Anderl, Jan; Lu, Xiongbin.
Affiliation
  • Liu Y; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang X; Department of Gynaecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Han C; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wan G; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Huang X; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ivan C; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Jiang D; Department of Gynaecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Rodriguez-Aguayo C; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lopez-Berestein G; Department of Gynaecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Rao PH; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Maru DM; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pahl A; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • He X; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sood AK; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ellis LM; Department of Paediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Anderl J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lu X; Heidelberg Pharma GmbH, Ladenburg, Germany.
Nature ; 597(7875): E6, 2021 Sep.
Article de En | MEDLINE | ID: mdl-34433970
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Nature Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Nature Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni